| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 W INNOVATION DR | MILWAUKEE | WI | 53226-4843 | MILWAUKEE | USA | R43TR003946 | Hypoxic chamber system for cost-effective and efficient screening of the effect of different oxygen levels on cellular growth and function | 000 | 1 | NIH | 11/9/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 W INNOVATION DR | MILWAUKEE | WI | 53226-4843 | MILWAUKEE | USA | R43CA221490 | Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy | 000 | 1 | NIH | 8/1/2022 | $0 |
| | 2022 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 W INNOVATION DR | MILWAUKEE | WI | 53226-4843 | MILWAUKEE | USA | R43CA228726 | Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas | 000 | 1 | NIH | 2/25/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $225,000 ) |
| | 2021 | 2021 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 INNOVATION DR STE 321 | WAUWATOSA | WI | 53226-4843 | MILWAUKEE | USA | R43TR003946 | Hypoxic chamber system for cost-effective and efficient screening of the effect of different oxygen levels on cellular growth and function | 000 | 1 | NIH | 8/5/2021 | $225,000 |
| | 2021 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 INNOVATION DR STE 321 | WAUWATOSA | WI | 53226-4843 | MILWAUKEE | USA | R43CA228726 | Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas | 000 | 1 | NIH | 8/30/2021 | $0 |
| | 2021 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 INNOVATION DR STE 321 | WAUWATOSA | WI | 53226-4843 | MILWAUKEE | USA | R43CA221490 | Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy | 000 | 1 | NIH | 3/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 INNOVATION DR STE 321 | WAUWATOSA | WI | 53226-4843 | MILWAUKEE | USA | R43CA221490 | Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy | 000 | 1 | NIH | 3/12/2020 | $0 |
| | 2020 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 10437 INNOVATION DR STE 321 | WAUWATOSA | WI | 53226-4843 | MILWAUKEE | USA | R43CA228726 | Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas | 000 | 1 | NIH | 7/27/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $600,000 ) |
| | 2018 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 4404 S 113 ST | GREENFIELD | WI | 53228-2565 | MILWAUKEE | USA | R43CA221490 | Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy | 000 | 1 | NIH | 3/1/2018 | $300,000 |
| | 2018 | 2018 | CELL REPROGRAMMING & THERAPEUTICS LLC | 4404 S 113 ST | GREENFIELD | WI | 53228-2565 | MILWAUKEE | USA | R43CA228726 | Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas | 000 | 1 | NIH | 8/30/2018 | $300,000 |
| | 2018 | 2015 | CELL REPROGRAMMING & THERAPEUTICS LLC | 4404 S 113 ST | GREENFIELD | WI | 53228-2565 | MILWAUKEE | USA | R43AG050352 | New Cell Reprogramming Technology to Produce Dopaminergic Neurons | 000 | 1 | NIH | 2/28/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $50,000 ) |
| | 2017 | 2017 | CELL REPROGRAMMING & THERAPEUTICS LLC | 4404 S 113 ST | GREENFIELD | WI | 53228-2565 | MILWAUKEE | USA | R43AG050352 | New Cell Reprogramming Technology to Produce Dopaminergic Neurons | 001 | 1 | NIH | 3/13/2017 | $50,000 |
| | 2017 | 2015 | CELL REPROGRAMMING & THERAPEUTICS LLC | 4404 S 113 ST | GREENFIELD | WI | 53228-2565 | MILWAUKEE | USA | R43AG050352 | New Cell Reprogramming Technology to Produce Dopaminergic Neurons | 000 | 1 | NIH | 2/17/2017 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $149,999 ) |
| | 2015 | 2015 | CELL REPROGRAMMING & THERAPEUTICS LLC | 4404 S 113 ST | GREENFIELD | WI | 53228 | MILWAUKEE | USA | R43AG050352 | New Cell Reprogramming Technology to Produce Dopaminergic Neurons | 000 | 1 | NIH | 9/11/2015 | $149,999 |
|
|
